Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · see citing works

A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood

Guindon, S., & Gascuel, O. (2003) · Systematic Biology · doi:10.1080/10635150390235520 · Cited by 16,698 · see citing works

Database resources of the National Center for Biotechnology Information: update

Wheeler, D. L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,691 · see citing works

Estimating the Global Burden of Endemic Canine Rabies

Hampson, K., Coudeville, L., Lembo, T., Sambo, M. B., Kieffer, A., Attlan, M., Barrat, J., Blanton, J. D., Briggs, D. J., Cleaveland, S., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003709 · Cited by 1,817 · see citing works

Gene splicing and mutagenesis by PCR-driven overlap extension

Heckman, K. L., & Pease, L. R. (2007) · Nature Protocols · doi:10.1038/nprot.2007.132 · Cited by 1,150 · see citing works

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,078 · see citing works

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,018 · see citing works

Database resources of the National Center for Biotechnology Information

Sayers, E. W., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., Church, D. M., DiCuccio, M. N., Edgar, R., Federhen, S., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn741 · Cited by 767 · see citing works

Clustal Omega

Sievers, F., & Higgins, D. G. (2014) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0313s48 · Cited by 760 · see citing works

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · see citing works

Industrialization of mAb production technology: The bioprocessing industry at a crossroads

Kelley, B. D. (2009) · mAbs · doi:10.4161/mabs.1.5.9448 · Cited by 668 · see citing works

Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren

(1890) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1207589 · Cited by 643 · see citing works

Laboratory Techniques in Rabies.

(1956) · The Quarterly Review of Biology · doi:10.1086/401609 · Cited by 584 · see citing works

Current status of rabies and prospects for elimination

Fooks, A. R., Banyard, A. C., Horton, D. L., Johnson, N., McElhinney, L. M., & Jackson, A. C. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62707-5 · Cited by 582 · see citing works

WHO Expert Consultation on Rabies. Second report.

(2013) · PubMed · Cited by 552 · see citing works

Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.

Manning, S. E., Rupprecht, C. E., Fishbein, D. B., Hanlon, C. A., Lumlertdacha, B., Guerra, M. A., Meltzer, M. I., Dhankhar, P., Vaidya, S. A., Jenkins, S. R., et al. (2008) · PubMed · Cited by 486 · see citing works

Broadly Neutralizing Antiviral Antibodies

Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 469 · see citing works

Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody

Cliquet, F., Aubert, M., & Sagné, L. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00212-3 · Cited by 432 · see citing works

Continuous cultures of fused cells secreting antibody of predefined specificity. 1975.

Köhler, G., & Milstein, C. (2005) · PubMed · Cited by 355 · see citing works

Molecular Diversity of the Lyssavirus Genus

Bourhy, H., Kissi, B., & Tordo, N. (1993) · Virology · doi:10.1006/viro.1993.1236 · Cited by 355 · see citing works

Laboratory Techniques In Rabies

Mortimer, P. P. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.11.955-b · Cited by 332 · see citing works

Evidence of TwoLyssavirusPhylogroups with Distinct Pathogenicity and Immunogenicity

Badrane, H., Bahloul, C., Perrin, P., & Tordo, N. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3268-3276.2001 · Cited by 315 · see citing works

Rabies Encephalitis in Malaria-Endemic Area, Malawi, Africa

Mallewa, M., Fooks, A. R., Banda, D. L., Chikungwa, P., Mankhambo, L., MOLYNEUX, E. M., Molyneux, M. E., & Solomon, T. (2007) · Emerging infectious diseases · doi:10.3201/eid1301.060810 · Cited by 191 · see citing works

Efficacy of rabies biologics against new lyssaviruses from Eurasia

Hanlon, C. A., Kuzmin, I. V., Blanton, J. D., Weldon, W. C., Manangan, J., & Rupprecht, C. E. (2005) · Virus Research · doi:10.1016/j.virusres.2005.03.009 · Cited by 189 · see citing works

Antigenic and molecular characterization of bat rabies virus in Europe

Bourhy, H., Kissi, B., Lafon, M., Sacramento, D. R. V., & Tordo, N. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.9.2419-2426.1992 · Cited by 176 · see citing works

Novel Lyssavirus in Bat, Spain

Aréchiga-Ceballos, N., Vázquez‐Morón, S., Berciano, J. M., Nicolás, O. G., López, C., Javier Juste, B., Nevado, C. R., Aguilar‐Setién, Á., & Echevarría, J. E. (2013) · Emerging infectious diseases · doi:10.3201/eid1905.121071 · Cited by 166 · see citing works

Shimoni bat virus, a new representative of the Lyssavirus genus

Kuzmin, I. V., Mayer, A. E., Niezgoda, M., Markotter, W., Agwanda, B. R., Breiman, R. F., & Rupprecht, C. E. (2010) · Virus Research · doi:10.1016/j.virusres.2010.01.018 · Cited by 161 · see citing works

Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants

Bakker, A. B. H., Marissen, W. E., Kramer, R. A., Papaneri, A. B., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Thijsse, S., Backus, H. H. J., de Kruif, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9062-9068.2005 · Cited by 155 · see citing works

Evolution of European bat lyssaviruses.

Amengual, B., Whitby, J. E., Cobo, J. S., King, A., & Bourhy, H. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-9-2319 · Cited by 150 · see citing works

First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity

Bakker, A. B. H., Python, C., Kissling, C. J., Pandya, P., Marissen, W. E., Brink, M. F., Lagerwerf, F. M., Worst, S., van Corven, E., Kostense, S., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.050 · Cited by 133 · see citing works

Ikoma Lyssavirus, Highly Divergent Novel Lyssavirus in an African Civet1

Marston, D. A., Horton, D. L., Ngeleja, C., Hampson, K., McElhinney, L. M., Banyard, A. C., Haydon, D. T., Cleaveland, S., Rupprecht, C. E., Bigambo, M., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1804.111553 · Cited by 128 · see citing works

Passive immunity in the prevention of rabies

Both, L., Banyard, A. C., van Dolleweerd, C. J., Horton, D. L., K‐C., J., & Fooks, A. R. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70340-1 · Cited by 127 · see citing works

Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses

Brookes, S. M., Parsons, G., Johnson, N., McElhinney, L. M., & Fooks, A. R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.037 · Cited by 124 · see citing works

Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison

Wright, E., Temperton, N. J., Marston, D. A., McElhinney, L. M., Fooks, A. R., & Weiss, R. A. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/000349-0 · Cited by 114 · see citing works

[On the development of immunity to diphtheria and tetanus in animals].

Behring, & Kitasato (1965) · PubMed · Cited by 113 · see citing works

[Field trials with rabies vaccine on persons bitten by rabid wolves].

Baltazard, M., & Bahmanyar, M. (1955) · PubMed · Cited by 112 · see citing works

Comparison of an Anti‐Rabies Human Monoclonal Antibody Combination with Human Polyclonal Anti‐Rabies Immune Globulin

Goudsmit, J., Marissen, W. E., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Papaneri, A. B., de Kruif, J., Dietzschold, B., Bakker, A. B. H., & Rupprecht, C. E. (2006) · The Journal of Infectious Diseases · doi:10.1086/500470 · Cited by 111 · see citing works

A new lyssavirus — fhe first endemic rabies-related virus recognized in Australia

Hooper, P. T., Lunt, R. A., Gould, A. R., Samaratunga, H., Hyatt, A. D., Gleeson, L. J., Rodwell, B. J., Rupprecht, C. E., Smith, J. S., & Murray, P. K. (1997) · Bulletin de l Institut Pasteur · doi:10.1016/s0020-2452(97)83529-5 · Cited by 105 · see citing works

Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates

Sloan, S. E., Hanlon, C. A., Weldon, W. C., Niezgoda, M., Blanton, J. D., Self, J., Rowley, K. J., Mandell, R. B., Babcock, G. J., Thomas, W. D., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.12.031 · Cited by 102 · see citing works

Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis

Marissen, W. E., Kramer, R. A., Papaneri, A. B., Weldon, W. C., Niezgoda, M., Faber, M., Slootstra, J. W., Meloen, R. H., der Horst, M. C.-V., Visser, T., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4672-4678.2005 · Cited by 96 · see citing works

Novel Vaccines to Human Rabies

Ertl, H. C. J. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000515 · Cited by 93 · see citing works

Quantifying Antigenic Relationships among the Lyssaviruses

Horton, D. L., McElhinney, L. M., Marston, D. A., Wood, J. L. N., Russell, C. A., Lewis, N. S., Kuzmin, I. V., Fouchier, R. A. M., Osterhaus, A. D. M. E., Fooks, A. R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01153-10 · Cited by 92 · see citing works

Use of hyperimmune antirabies serum concentrates in experimental rabies

Koprowski, H., der Scheer, J. C. E. V., & Black, J. (1950) · The American Journal of Medicine · doi:10.1016/0002-9343(50)90224-5 · Cited by 86 · see citing works

A Human Monoclonal Antibody Cocktail as a Novel Component of Rabies Postexposure Prophylaxis

de Kruif, J., Bakker, A. B. H., Marissen, W. E., Kramer, R. A., Throsby, M., Rupprecht, C. E., & Goudsmit, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145053 · Cited by 85 · see citing works

Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons.

Atanasiu, P. I., BAHMANYAR, M., BALTAZARD, M., FOX, J. P., Habel, K., Kaplan, M. M., KISSLING, R. E., KOMAROV, A., Koprowski, H., Lépine, P. R., et al. (1956) · Europe PMC (PubMed Central) · Cited by 80 · see citing works

The fight against rabies in Africa: From recognition to action

Dodet, B. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.030 · Cited by 73 · see citing works

A Simplified 4-Site Economical Intradermal Post-Exposure Rabies Vaccine Regimen: A Randomised Controlled Comparison with Standard Methods

Warrell, M. J., Riddell, A., Yu, L., Phipps, J. C., Diggle, L., Bourhy, H., Deeks, J. J., Fooks, A. R., Audry, L., Brookes, S. M., et al. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000224 · Cited by 72 · see citing works

Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis

Hanlon, C. A., Demattos, C. A., DeMattos, C. C., Niezgoda, M., Hooper, D. C., Koprowski, H., Notkins, A. L., & Rupprecht, C. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00135-9 · Cited by 72 · see citing works

A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa

Wright, E., McNabb, S., Goddard, T., Horton, D. L., Lembo, T., Nel, L. H., Weiss, R. A., Cleaveland, S., & Fooks, A. R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.024 · Cited by 57 · see citing works

Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects.

Cabasso, V. J., Loofbourow, J. C., Roby, R. E., & Anuskiewicz, W. (1971) · Europe PMC (PubMed Central) · Cited by 53 · see citing works

Antibody Response to a Human Diploid Cell Rabies Vaccine

Cabasso, V. J., Dobkin, M. B., Roby, R. E., & Hammar, A. H. (1974) · Applied Microbiology · doi:10.1128/am.27.3.553-561.1974 · Cited by 48 · see citing works

Conservation of Binding Epitopes for Monoclonal Antibodies on the Rabies Virus Glycoprotein

Kuzmina, N. A. (2013) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.1000061 · Cited by 45 · see citing works

The incurable wound revisited: progress in human rabies prevention?

Hanlon, C. A., Niezgoda, M., Morrill, P., & Rupprecht, C. E. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00516-8 · Cited by 43 · see citing works

Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?

Bourhy, H., Goudal, M., Mailles, A., Sadkowska-Todys, M., Dacheux, L., & Zeller, H. G. (2009) · Eurosurveillance · doi:10.2807/ese.14.13.19166-en · Cited by 32 · see citing works

Monoclonal antibodies for the prevention of rabies: theory and clinical practice

Nagarajan, T., Marissen, W. E., & Rupprecht, C. E. (2014) · Antibody Technology Journal · doi:10.2147/anti.s33533 · Cited by 29 · see citing works

Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination.

Wiktor, T. J., Lerner, R. A., & Koprowski, H. (1971) · PubMed · Cited by 28 · see citing works

Antiserum in the prophylaxis of rabies.

Habel, K. (1954) · PubMed · Cited by 25 · see citing works

Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine.

Archer, B. G., & Dierks, R. E. (1968) · PubMed · Cited by 22 · see citing works

Human Rabies Immune Globulin: Progress Report

Sikes, R. K. (1969) · Public Health Reports (1896-1970) · doi:10.2307/4593681 · Cited by 17 · see citing works

Rabies prophylaxis in man.

Habel, K. (1957) · PubMed · Cited by 13 · see citing works

Rabies Prophylaxis in Man

Habel, K. (1957) · Public Health Reports (1896-1970) · doi:10.2307/4589865 · Cited by 12 · see citing works

Properties of rabies immune globulin of human origin

Cabasso, V. J. (1974) · Journal of Biological Standardization · doi:10.1016/s0092-1157(74)80007-7 · Cited by 11 · see citing works

The spread and evolution of rabies virus: conquering new frontiers

Fisher, C. R., Streicker, D. G., & Schnell, M. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.11 · Cited by 344 · see citing works

Passive immunotherapy of viral infections: ‘super-antibodies’ enter the fray

Walker, L., & Burton, D. (2018) · Nature reviews. Immunology · doi:10.1038/nri.2017.148 · Cited by 242 · see citing works

Antibody therapies for the prevention and treatment of viral infections

Salazar, G. T., Zhang, N., Fu, T., & An, Z. (2017) · npj Vaccines · doi:10.1038/s41541-017-0019-3 · Cited by 171 · see citing works

mRNA mediates passive vaccination against infectious agents, toxins, and tumors

Thran, M., Mukherjee, J., Pönisch, M., Fiedler, K., Thess, A., Mui, B. L., Hope, M. J., Tam, Y. K., Horscroft, N., Heidenreich, R., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707678 · Cited by 166 · see citing works

Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies

Rupprecht, C. E., Kuzmin, I. V., & Meslin, F. X. (2017) · F1000Research · doi:10.12688/f1000research.10416.1 · Cited by 164 · see citing works

Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study

Gogtay, N., Munshi, R., Narayana, D. H. A., Mahendra, B. J., Kshirsagar, V. D., Gunale, B., Moore, S. M., Cheslock, P. S., Thaker, S. J., Deshpande, S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix791 · Cited by 91 · see citing works

Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever

Fels, J. M., Maurer, D. P., Herbert, A. S., Wirchnianski, A. S., Vergnolle, O., Cross, R. W., Abelson, D. M., Moyer, C. L., Mishra, A. K., Aguilan, J. T., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.001 · Cited by 87 · see citing works

The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target

Ragotte, R. J., Higgins, M. K., & Draper, S. J. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.04.003 · Cited by 84 · see citing works

Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline

Sparrow, E. G., Torvaldsen, S., Newall, A. T., Wood, J., Sheikh, M., Kiény, M. P., & Abela-Ridder, B. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.11.004 · Cited by 77 · see citing works

Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy

de Melo, G. D., Hellert, J., Gupta, R., Corti, D., & Bourhy, H. (2022) · Current Opinion in Virology · doi:10.1016/j.coviro.2022.101204 · Cited by 67 · see citing works

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody

Callaway, H., Zyla, D. S., Larrous, F., de Melo, G. D., Hastie, K. M., Díaz-Avalos, R., Agarwal, A., Corti, D., Bourhy, H., & Saphire, E. O. (2022) · Science Advances · doi:10.1126/sciadv.abp9151 · Cited by 67 · see citing works

Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies

Ng, W. M., Fedosyuk, S., English, S., Augusto, G. S., Berg, A., Thorley, L., Haselon, A.-S., Segireddy, R. R., Bowden, T. A., & Douglas, A. D. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.07.014 · Cited by 64 · see citing works

SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies

Chao, T.-Y., Ren, S., Shen, E., Moore, S. M., Zhang, S., Chen, L., Rupprecht, C. E., & Tsao, E. I. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006133 · Cited by 56 · see citing works

A combination of two human monoclonal antibodies cures symptomatic rabies

de Melo, G. D., Sonthonnax, F., Lepousez, G., Jouvion, G., Minola, A., Zatta, F., Larrous, F., Kergoat, L., Mazo, C., Moigneu, C., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012628 · Cited by 56 · see citing works

Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein

Hellert, J., Buchrieser, J., Larrous, F., Minola, A., de Melo, G. D., Soriaga, L. B., England, P., Haouz, A., Telenti, A., Schwartz, O., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14398-7 · Cited by 55 · see citing works

Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination

Rupprecht, C. E., & Salahuddin, N. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1627205 · Cited by 49 · see citing works

Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses

Hellgren, F., Cagigi, A., Cerveira, R. A., Ols, S., Kern, T., Lin, A., Eriksson, B., Dodds, M., Jasny, E., Schwendt, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39421-5 · Cited by 49 · see citing works

Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses

Pont, V. D., Plemper, R. K., & Schnell, M. J. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.12.009 · Cited by 47 · see citing works

Advances in the progress of monoclonal antibodies for rabies

Fan, L., Zhang, L., Li, J., & Zhu, F. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2026713 · Cited by 45 · see citing works

Pyrimethamine inhibits rabies virus replication in vitro

Rogée, S., Larrous, F., Jochmans, D., Khalifa, Y. B., Neyts, J. H., & Bourhy, H. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.10.016 · Cited by 31 · see citing works

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

Esposito, S., Amirthalingam, G., Bassetti, M., Blasi, F., Rosa, F. G. D., Halasa, N., Hung, I. F., Osterhaus, A. D. M. E., Tan, T. Q., Torres, J. P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162342 · Cited by 32 · see citing works

An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection

Zhou, D., Cheng, R., Yao, Y., Zhang, G., Li, X., Wang, B., Wang, Y., Yu, F., Yang, S., Liu, H., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00954-5 · Cited by 29 · see citing works

Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses

Evans, J. S., Selden, D., Wu, G., Wright, E., Horton, D. L., Fooks, A. R., & Banyard, A. C. (2018) · Journal of General Virology · doi:10.1099/jgv.0.000998 · Cited by 28 · see citing works

Dermaseptins as potential antirabies compounds

Mechlia, M. B., Belaïd, A., Castel, G., Jallet, C., Mansfield, K. L., Fooks, A. R., Hani, K., & Tordo, N. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.066 · Cited by 28 · see citing works

In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants

Franka, R., Carson, W. C., Ellison, J. A., Taylor, S., Smith, T., Kuzmina, N. A., Kuzmin, I., Marissen, W. E., & Rupprecht, C. E. (2017) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed2030048 · Cited by 27 · see citing works

Human Rabies Survivors in India: An Emerging Paradox?

Mani, R. S. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004774 · Cited by 25 · see citing works

Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models

Zhai, L., Wang, H., Zhao, W. G., Zhang, S., Miao, F., Cao, Y., Chen, C., Li, Y., Gao, J., Ruoyun, L., et al. (2022) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2022.102267 · Cited by 24 · see citing works

In Vivo Efficacy of SYN023, an Anti-Rabies Monoclonal Antibody Cocktail, in Post-Exposure Prophylaxis Animal Models

Chao, T.-Y., Zhang, S., Chen, L., Tsao, E. I., & Rupprecht, C. E. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5010031 · Cited by 22 · see citing works

Update on lyssaviruses and rabies: will past progress play as prologue in the near term towards future elimination?

Rohde, R. E., & Rupprecht, C. E. (2020) · Faculty Reviews · doi:10.12703/b/9-9 · Cited by 22 · see citing works

More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation

Toon, K., Bentley, E. M., & Mattiuzzo, G. (2021) · Viruses · doi:10.3390/v13020217 · Cited by 21 · see citing works

Vaccinations for Neuroinfectious Disease: A Global Health Priority

Leibovitch, E. C., & Jacobson, S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0453-3 · Cited by 22 · see citing works

Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies

Kreer, C., Gruell, H., Mora, T., Walczak, A. M., & Klein, F. (2020) · Vaccines · doi:10.3390/vaccines8010013 · Cited by 21 · see citing works

Development of a protective inactivated vaccine against Crimean–Congo hemorrhagic fever infection

Berber, E., Çanakoğlu, N., Tonbak, Ş., & Özdarendeli, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08161 · Cited by 21 · see citing works

Research progress on neutralizing epitopes and antibodies for the Rabies virus

Shi, C., Sun, P., Pan, Y., Liu, L., Li, T., Liu, W., Wang, M., Zheng, X., & Zheng, W. (2022) · Infectious Medicine · doi:10.1016/j.imj.2022.09.003 · Cited by 21 · see citing works

Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies

Naranjo‐Gómez, M., Lambour, J., Piechaczyk, M., & Pelegrín, M. (2018) · JCI Insight · doi:10.1172/jci.insight.97339 · Cited by 22 · see citing works

Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy

Zorzan, M., Castellan, M., Gasparotto, M., de Melo, G. D., Zecchin, B., Leopardi, S., Chen, A., Rosato, A., Angelini, A., Bourhy, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186063 · Cited by 19 · see citing works

mAb therapy controls CNS‐resident lyssavirus infection via a CD4 T cell‐dependent mechanism

Mastraccio, K. E., Huaman, C., Coggins, S. A., Clouse, C., Rader, M., Yan, L., Mandal, P., Hussain, I., Ahmed, A. E., Ho, T., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216394 · Cited by 19 · see citing works

Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups

Fisher, C. R., Lowe, D. E., Smith, T. G., Yang, Y., Hutson, C. L., Wirblich, C., Cingolani, G., & Schnell, M. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107920 · Cited by 19 · see citing works

Efficient isolation of rare B cells using next-generation antigen barcoding

Hurtado, J., Flynn, C., Lee, J. H., Salcedo, E., Cottrell, C. A., Skog, P. D., Burton, D. R., Nemazee, D. A., Schief, W. R., Landais, E., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.962945 · Cited by 19 · see citing works

Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses

Evans, J. S., Wu, G., Selden, D., Buczkowski, H., Thorne, L., Fooks, A. R., & Banyard, A. C. (2018) · Viruses · doi:10.3390/v10030130 · Cited by 17 · see citing works

A research agenda to reinforce rabies control: A qualitative and quantitative prioritization

Neevel, A. M. G., Hemrika, T., Claassen, E., & van de Burgwal, L. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006387 · Cited by 16 · see citing works

Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations

Aditham, A. K., Radford, C. E., Carr, C. R., Jasti, N., King, N. P., & Bloom, J. D. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.04.018 · Cited by 15 · see citing works

Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics

Scott, T. P., & Nel, L. H. (2021) · Viruses · doi:10.3390/v13050881 · Cited by 15 · see citing works

A phylogenetic study of new rabies virus strains in different regions of Iran

Heydarabadi, F. H., Baessi, K., Bashar, R., Fazeli, M., & Sheikholeslami, F. (2020) · Virus Genes · doi:10.1007/s11262-020-01752-6 · Cited by 14 · see citing works

Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection

Wang, X., Zhou, P., Wu, M., Yang, K., Guo, J., Wang, X., Li, J., Fang, Z., Wang, G., Xing, M., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0206-5 · Cited by 14 · see citing works

Recombinant monoclonal antibodies for rabies post-exposure prophylaxis

Ilina, E. N., Ларина, М. В., Aliev, T. K., Dolgikh, D. A., & Kirpichnikov, M. P. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918010017 · Cited by 14 · see citing works

Rabies virus glycoprotein: Structure, function, and antivirals

Yu, Y., Yang, F., Lin, S., Chen, Z., Shu, S., Yu, Y., He, B., Cao, Y., & Lu, G. (2025) · hLife · doi:10.1016/j.hlife.2025.06.003 · Cited by 11 · see citing works

Establishment of a Chinese street rabies virus library and its application for detecting neutralizing activity

Yu, P., Tao, X., Wang, L., Tang, Q., Fan, L.-Y., Zhang, S., Liu, S., Lu, X., Wu, G., & Zhu, W. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0500-x · Cited by 11 · see citing works

Development of a novel bispecific antibody GR1801 for rabies

Long, C., Wang, W., Hao, X., Yu, C., Feng, Y., Tu, C., Sun, S., Bian, L., Liu, Z., & Wang, L. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29016 · Cited by 10 · see citing works

Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus

Kim, P., Keum, S. J., Osinubi, M. O. V., Franka, R., Shin, J. Y., Park, S. T., Kim, M. S., Park, M. J., Lee, S. Y., Carson, W. C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186380 · Cited by 10 · see citing works

Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters

Bernard, M., Boudet, F., Pineda-Peña, A.-C., & Guinet-Morlot, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-10281-1 · Cited by 10 · see citing works

Molecular convergence of neutralizing antibodies in human revealed by repeated rabies vaccination

Fujisawa, M., Onodera, T., Kuroda, D., Kewcharoenwong, C., Sasaki, M., Itakura, Y., Yumoto, K., Nithichanon, A., Ito, N., Takeoka, S., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01073-5 · Cited by 9 · see citing works

Development of an oral gut-targeted rabies virus-like particles (RVLPs) vaccine with mucosal immune adjuvant LTB via delivering of localized-release microparticles

Niu, J., Zhao, Z., Zhang, T., Liu, Q., Huang, L., Li, S., Liu, H., Yu, S., Li, L., Jia, H., et al. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2515406 · Cited by 8 · see citing works

Design and construction of multi epitope- peptide vaccine candidate for rabies virus

Odhar, H. A. (2023) · Bioinformation · doi:10.6026/97320630019167 · Cited by 8 · see citing works

Structural insight into rabies virus neutralization revealed by an engineered antibody scaffold

Kedari, A., Iheozor-Ejiofor, R. P., Salminen, P., Uğurlu, H., Mäkelä, A. R., Levanov, L., Vapalahti, O. P., Hytönen, V. P., Saksela, K., & Rissanen, I. (2024) · Structure · doi:10.1016/j.str.2024.10.002 · Cited by 7 · see citing works

Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models

Huang, F., Ren, M., Pei, J., Mei, H., Sui, B., Wu, Q. D., Chai, B., Yang, R., Zhou, M., Fu, Z. F., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.702273 · Cited by 7 · see citing works

Nouveaux aspects de la lutte contre la rage

Bourhy, H., de Melo, G. D., & Tarantola, A. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2020.09.036 · Cited by 7 · see citing works

A SynB1-conjugated antibody cocktail crosses the blood–brain barrier to produce a therapeutic effect on rabies

Ren, Z., Wang, C., Wang, H., Wu, Q., Hou, Q., Qi, X., He, W., Zhang, X., Wan, J., Fu, Z. F., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516465122 · Cited by 6 · see citing works

Structural comparison of the C-terminal domain of functionally divergent lyssavirus P proteins

Sugiyama, A., Nomai, T., Jiang, X., Minami, M., Yao, M., Maenaka, K., Ito, N., Gooley, P. R., Moseley, G. W., & Ose, T. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.195 · Cited by 6 · see citing works

The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III rabies post-exposure population: A randomized, double-blind, positive control, phase III clinical trial.

Liu, X., Li, J., Zha, Y., Wang, Z., Jiang, Y., Zhang, X., Guo, J., Yu, J., Li, X., Zhang, Q., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127289 · Cited by 5 · see citing works

Monoclonal antibodies for rabies post-exposure prophylaxis: A paradigm shift in passive immunization

Gongal, G., & Sampath, G. (2020) · Archives of Preventive Medicine · doi:10.17352/apm.000017 · Cited by 5 · see citing works

Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs

Chorpunkul, A., Boonyuen, U., Limkittikul, K., Saengseesom, W., Phongphaew, W., Putchong, I., Chankeeree, P., Theerawatanasirikul, S., Hajitou, A., Benjathummarak, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-73339-2 · Cited by 4 · see citing works

Passive Immunity in Rabies Prophylaxis

Rupprecht, C. E., Yager, M. L., & Newhouse, R. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-21084-7_7 · Cited by 4 · see citing works

Public health management of humans at risk

Briggs, D. J., & Moore, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818705-0.00016-9 · Cited by 4 · see citing works

Structural basis for broad neutralization of rabies virus by an antibody cocktail SYN023

Cao, L., Qu, J., Zhang, C., Chen, R., Wang, J., Fehlner‐Gardiner, C., Niezgoda, M., Satheshkumar, P. S., Wang, X., & Tsao, E. I. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2547724 · Cited by 3 · see citing works

Comparison of rabies virus protection by single chain and leucine zipper Fv fragments cocktail derived from a monoclonal antibody cocktail

Xi, H., Meng, X., Gu, T., Li, Z., Cheng, Y., Sun, Q., Zhang, K., Kong, W., & Wu, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.07.003 · Cited by 3 · see citing works

Characterization of a human–mouse chimeric monoclonal antibody targeting rabies virus glycoprotein

Cai, M., Hu, Z., Yang, Y., Mao, T., Liu, Y., Lu, G., Yang, F., Qi, J., Huang, W., & Wang, Y. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28954 · Cited by 3 · see citing works

Developing a human monoclonal antibody combination CRM25 to prevent rabies after exposure

Long, C., Wang, W., Xu, G., Xu, G., Yu, C., & Wang, L. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107383 · Cited by 3 · see citing works

Elimination of Rabies – A Missed Opportunity

Müller, T., Rupprecht, C. E., Fooks, A. R., Both, L., Smith, S. P., Gibson, A. P., Lohr, F., Fahrion, A. S., & Freuling, C. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-85877-3_21-1 · Cited by 3 · see citing works

Cross-Neutralization Activities of Antibodies against 18 Lyssavirus Glycoproteins

Inoue, Y., Kaku, Y., Harada, M., Ishijima, K., Kuroda, Y., Tatemoto, K., Virhuez-Mendoza, M., Nishino, A., Yamamoto, T., Inoue, S., et al. (2023) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2023.400 · Cited by 3 · see citing works

New treatments to rabies virus infections

Yuan, S., Zhang, Z.-W., Jiang, S.-C., Li, Z.-L., & Hu, J. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106380 · Cited by 2 · see citing works

Structural overview of lyssavirus glycoproteins, antibodies, and receptors

Callaway, H. (2026) · Journal of Virology · doi:10.1128/jvi.01786-25 · Cited by 2 · see citing works

Elimination of Rabies: A Missed Opportunity

Müller, T., Rupprecht, C. E., Fooks, A. R., Both, L., Smith, S. P., Gibson, A. P., Lohr, F., Fahrion, A. S., & Freuling, C. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-27164-9_21 · Cited by 2 · see citing works

RECOMBINANT ANTIBODIES IN ANTI-VIRAL THERAPY: ACHIEVEMENTS AND PERSPECTIVES

Oksanich, A. S., Nikonova, A. A., & Zverev, V. V. (2018) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2018-6-114-123 · Cited by 2 · see citing works

Revisiting rabies virus neutralizing antibodies through infecting BALB/c mice with live rabies virus

Qin, Y., Smith, T. G., Jackson, F. R., Gallardo-Romero, N. F., Morgan, C. N., Olson, V. A., Hutson, C. L., & Wu, X. (2018) · Virus Research · doi:10.1016/j.virusres.2018.02.012 · Cited by 2 · see citing works

Rabies-Monoclonal Antibody - A Perspective

Panda, M. (2022) · JOURNAL OF COMMUNICABLE DISEASES · doi:10.24321/0019.5138.202285 · Cited by 2 · see citing works

Establishment of serological neutralizing tests using pseudotyped viruses for comprehensive detection of antibodies against all 18 lyssaviruses

Inoue, Y., Kaku, Y., Harada, M., Ishijima, K., Kuroda, Y., Tatemoto, K., Virhuez-Mendoza, M., Nishino, A., Yamamoto, T., Park, E., et al. (2023) · Journal of Veterinary Medical Science · doi:10.1292/jvms.23-0463 · Cited by 1 · see citing works

Antigenic landscape of rabies and related lyssaviruses revealed by cryo-EM

Callaway, H., Zyla, D. S., Hastie, K. M., Harkins, S., Kothalawalage, S., Samarasinghe, N., Flynn, A., Hariharan, C., Yin, J., Corti, D., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117993 · Cited by 1 · see citing works

Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis

Wu, M., Peng, X., Xu, W., Zhang, H., Fang, L., Liu, X., Miao, F., Liu, Q., Mi, S., Xiao, Y., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.70068 · Cited by 1 · see citing works

CURRENT STATE OF PASSIVE RABIES IMMUNOPROPHYLAXIS

Savenkova, A. A., Генералов, С. В., Абрамова, Е. Г., Shulgina, I., Анатольевна, Л. О., & Никифоров, А. К. (2025) · Problems of Biological Medical and Pharmaceutical Chemistry · doi:10.29296/25877313-2025-02-05 · Cited by 1 · see citing works

Molecular basis of two broad-spectrum antibodies neutralizing rabies virus and other phylogroup-I lyssaviruses by blocking structural transition between the pleckstrin-homology and fusion domains in the glycoprotein

Yang, F., Zhai, L., Yin, K., Lin, S., Yang, J., Ye, F., Chen, Z., Shu, S., Yu, Y., Guo, L., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142570 · Cited by 1 · see citing works

Rabies: The Vet-verse of Madness

(2023) · International Journal of Agriculture and Biosciences · doi:10.47278/book.oht/2023.17 · Cited by 1 · see citing works

A cocktail of engineered chimeric antibodies targeting the central nervous system produces a broad-spectrum therapeutic effect for symptomatic rabiesPreprint

Zhao, L., Ren, Z., Wang, C., Wang, H., Wu, Q. D., Hou, Q., Qi, X., He, W., Zhang, X., Wan, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4838561/v1 · Cited by 1 · see citing works

Generation of Arctic-like Rabies Viruses Containing Chimeric Glycoproteins Enables Serological Potency StudiesPreprint

Bentley, E. M., Ali, R., Horton, D. L., Corti, D., Banyard, A. C., Fooks, A. R., & Wright, E. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/150300

Generation and Characterization of a Neutralizing Monoclonal Antibody Against Rabies Virus

Ilina, E. N., Солопова, О. Н., Сергеевич, Б. Д., Ларина, М. В., Aliev, T. K., Гребенникова, Т. В., Анатольевна, Л. М., Zaykova, O. N., Sveshnikov, P. G., Dolgikh, D. A., et al. (2018) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162019010072

What Do Antibody Studies Tell Us about Viral Infections?

Ilinykh, P. A., & Huang, K. (2022) · Pathogens · doi:10.3390/pathogens11050560

Pseudotyped Viruses for Lyssavirus

Wang, W., Long, C., Wang, L., & Wang, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-0113-5_10

Isolation and characterization of rabies monoclonal antibody charge variants

Divase, A., Pisal, S. S., Dake, M. S., Dakshinamurthy, P. K., Reddy, P. A., Dhere, R. M., Kamat, C. D., Chahar, D. S., Pal, J. K., & Nawani, N. N. (2024) · Electrophoresis · doi:10.1002/elps.202300221

Generation and selection of novel human-neutralizing single chain variable fragments against rabies virus from immunized phage display libraries

Chorpunkul, A., Boonyuen, U., Limkittikul, K., Saengseesom, W., Phongphaew, W., Putchong, I., Yamabhai, M., Hajitou, A., Benjathummarak, S., Lekcharoensuk, P., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42923

Immunology

Hooper, D. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29979-7.00014-3

Public health management of humans at risk

Moore, S. M., Keating, C. C., & MANALO, D. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29979-7.00015-5

Rabies prevention through the ages

Briggs, D. J., & Tarantola, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29979-7.00016-7

Monoclonal antibodies targeting the rabies virus glycoprotein promotes viral clearance and Fc-dependent neuroprotection in the infected brainPreprint

Kim, S., Coléon, A., Larrous, F., Kergoat, L., Mougari, S., Lannoy, J., Tiago, M. S. F., Hardy, D., Kornobis, É., Rey, F. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.13.699195

Coopération de la phosphoprotéine et de la protéine de matrice du virus de la rage dans la modulation des voies de signalisation Jak/Stat et NF-!B et développement d’une approche thérapeutique

Sonthonnax, F. (2017) · doi:10.70675/93be8d4dzc4b9z4f85za9c0z8bfbda61e63a

Rôle des polynucléaires neutrophiles et du FcgRIV dans les effets vaccinaux induit par immunothérapie antivirale par anticorps monoclonaux

Lambour, J. (2018) · theses.fr (ABES) · doi:10.70675/94c1787fz8162z4fc5z8f76z364019c13206

A Fully Human Derived Monoclonal Antibody Provides Potent Pre‐ and Postexposure Protection Against Rabies Virus

Mo, R., Xu, J., Zheng, H., Yin, T., Cong, H., Chen, L., Yan, F.-H., Feng, N., Wang, T., Wang, J., et al. (2026) · Transboundary and Emerging Diseases · doi:10.1155/tbed/3021186

Safety and operational feasibility of single versus cocktail rabies monoclonal antibodies for post-exposure prophylaxis in a resource-limited setting

Fotedar, N., & Ravish, H. S. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0014274

Overcoming rabies immune evasion via monoclonal antibody therapeutics

Uddin, M. J., King, J., Broder, C. C., & Schaefer, B. C. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.06.014

Rabies viral RNA and antibody response after post-exposure prophylaxis: Implications for blood donor deferral

Singh, A. D., Oberoi, S., Singh, K., Kaur, S., Garg, M., Bassi, R., Kaur, A., Attri, K., & Gajebasia, S. (2026) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-026-00312-4

Identification of a novel conserved B-cell epitope in the glycoprotein of rabies virus

Chen, Y., Zhang, X., Qi, Y., Liu, H., Liu, E., Zhu, X., Zhou, J., Liang, C., Wu, S., & Wang, A. (2026) · Medical Microbiology and Immunology · doi:10.1007/s00430-026-00887-x

Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis

Wu, M., Peng, X., Xu, W., Zhang, H., Fang, L., Liu, X., Miao, F., Liu, Q., Mi, S., Xiao, Y., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.70068 · Cited by 1 · see citing works

Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans

Müller, T., Dietzschold, B., Ertl, H. C. J., Fooks, A. R., Freuling, C. M., Fehlner‐Gardiner, C., Kliemt, J., Meslin, F. X., Rupprecht, C. E., Tordo, N., et al. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000542 · Cited by 126 · see citing works

A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis

Kim, P., Ahn, J. S., Kim, C. M., Seo, J. M., Keum, S. J., Lee, H. J., Choo, M. J., Kim, M. S., Lee, J. Y., Maeng, K. E., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256779 · Cited by 13 · see citing works

Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus

Kim, P., Keum, S. J., Osinubi, M. O. V., Franka, R., Shin, J. Y., Park, S. T., Kim, M. S., Park, M. J., Lee, S. Y., Carson, W. C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186380 · Cited by 10 · see citing works

A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis

Ejemel, M., Smith, T. G., Greenberg, L., Carson, W. C., Lowe, D. E., Yang, Y., Jackson, F. R., Morgan, C. N., Martin, B. E., Kling, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13527-0 · Cited by 15 · see citing works